SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

OMB Number:

3235-0287

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Estimated average burden

hours per response:

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*

Miller Franklin J

(Last)

(First)

(Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH

UT

84095

JORDAN

2. Issuer Name and Ticker or Trading Symbol

5. Relationship of Reporting Person(s) to Issuer

MERIT MEDICAL SYSTEMS INC[

(Check all applicable)

MMSI ]

X

Director

10% Owner

Officer (give title

Other (specify

3. Date of Earliest Transaction (Month/Day/Year)

below)

below)

05/24/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable

05/29/2019

Line)

X Form filed by One Reporting Person

Form filed by More than One Reporting

Person

(City)(State)(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction

2A. Deemed

3.

4. Securities Acquired (A) or

5. Amount of

6. Ownership

7. Nature

Date

Execution Date,

Transaction

Disposed Of (D) (Instr. 3, 4

Securities

Form: Direct

of Indirect

(Month/Day/Year)

if any

Code (Instr.

and 5)

Beneficially

(D) or

Beneficial

(Month/Day/Year)

8)

Owned

Indirect (I)

Ownership

Following

(Instr. 4)

(Instr. 4)

Code

V

Amount

(A) or

Price

Reported

Transaction(s)

(D)

(Instr. 3 and 4)

By the

Franklin

J. Miller

Common Stock, No Par Value

18,193

I

and

Bonnie

A. Miller

Family

Trust

Common Stock, No Par Value

14,038

D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Transaction

3A. Deemed

4.

5. Number

6. Date Exercisable and

7. Title and

8. Price

9. Number of

10.

11. Nature

Derivative

Conversion

Date

Execution Date,

Transaction

of

Expiration Date

Amount of

of

derivative

Ownership

of Indirect

Security

or Exercise

(Month/Day/Year)

if any

Code (Instr.

Derivative

(Month/Day/Year)

Securities

Derivative

Securities

Form:

Beneficial

(Instr. 3)

Price of

(Month/Day/Year)

8)

Securities

Underlying

Security

Beneficially

Direct (D)

Ownership

Derivative

Acquired

Derivative

(Instr. 5)

Owned

or Indirect

(Instr. 4)

Security

(A) or

Security (Instr. 3

Following

(I) (Instr.

Disposed

and 4)

Reported

4)

of (D)

Transaction(s)

(Instr. 3, 4

(Instr. 4)

and 5)

Amount

or

Number

Date

Expiration

of

Code

V

(A)

(D)

Exercisable

Date

Title

Shares

Non-

qualified

stock

$9.95

05/22/2014(1)

05/22/2020

Common

20,000

20,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$13.99

06/11/2015(2)

06/11/2021

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$20.27

05/22/2016(3)

05/22/2022

Common

25,000

25,000

D

options

Stock

(right to

buy)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Transaction

3A. Deemed

4.

5. Number

6. Date Exercisable and

7. Title and

8. Price

9. Number of

10.

11. Nature

Derivative

Conversion

Date

Execution Date,

Transaction

of

Expiration Date

Amount of

of

derivative

Ownership

of Indirect

Security

or Exercise

(Month/Day/Year)

if any

Code (Instr.

Derivative

(Month/Day/Year)

Securities

Derivative

Securities

Form:

Beneficial

(Instr. 3)

Price of

(Month/Day/Year)

8)

Securities

Underlying

Security

Beneficially

Direct (D)

Ownership

Derivative

Acquired

Derivative

(Instr. 5)

Owned

or Indirect

(Instr. 4)

Security

(A) or

Security (Instr. 3

Following

(I) (Instr.

Disposed

and 4)

Reported

4)

of (D)

Transaction(s)

(Instr. 3, 4

(Instr. 4)

and 5)

Amount

or

Number

Date

Expiration

of

Code

V

(A)

(D)

Exercisable

Date

Title

Shares

Non-

qualified

stock

$18.8

05/26/2017(4)

05/26/2023

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$34.4

05/24/2018(5)

05/24/2024

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$50.5

06/07/2019(6)

06/07/2025

Common

25,000

25,000

D

options

Stock

(right to

buy)

Non-

qualified

stock

$52.17(7)

05/24/2019

A

13,750

05/24/2020(8)

05/24/2026

Common

13,750

$0

13,750

D

options

Stock

(right to

buy)

Explanation of Responses:

  1. Becomes exercisable in equal annual installments of 20% commencing 05/22/2014.
  2. Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
  3. Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
  4. Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
  5. Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
  6. Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
  7. Due to a clerical error, the reporting person is filing this Form 4/A to correct the exercise price of the derivative security reported on the initial Form 4 filed on May 29, 2019, from $53.95 to $52.17.
  8. Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

Remarks:

Brian G. Lloyd, Attorney-in-

05/29/2019

Fact

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Attachments

  • Original document
  • Permalink

Disclaimer

Merit Medical Systems Inc. published this content on 29 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 May 2019 23:38:03 UTC